Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Vehicle-controlled, Parallel Group, Dose-Ranging, Multi-center Study of the Efficacy and Safety of Nexagon® in the Treatment of Participants With Venous Leg Ulcers

NCT00820196 is registered in ClinicalTrials.gov with OcuNexus Therapeutics, Inc. as lead sponsor.

NCT NCT00820196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00820196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Vehicle-controlled, Parallel Group, Dose-Ranging, Multi-center Study of the Efficacy and Safety of Nexagon® in the Treatment of Participants With Venous Leg Ulcers
Lead sponsor
OcuNexus Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
May 31, 2010
Enrollment
98 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

venous ulcer